Seeking Alpha

ResMed (RMD +7%) trades up after beating FQ3 consensus estimates late yesterday. Net income...

ResMed (RMD +7%) trades up after beating FQ3 consensus estimates late yesterday. Net income jumped 21% Y/Y, driven by higher-than-expected gross margins from strong growth in masks and a shift to higher-margin flow generators. Separately, Goldman ups the shares to Buy on the back of the blowout quarter.

Check out Seeking Alpha’s new Earnings Center »

Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs